Home › Targets › DLL4

DLL4 (1 companies · 2 programs)

Companies with an active program directed at DLL4.

Compass Therapeutics, Inc. CMPX

tovecimig — Biliary Tract Cancer Phase 2
tovecimib — Colorectal Cancer Phase 2